Design a Western Blot for C1S

Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.

Isoforms · The supplied record lists one isoform and no alternative sequence. It therefore provides no isoform-based explanation for another band. Evaluate other possibilities against the sample and blot conditions.

PTM · UniProt lists (3R)-3-hydroxyasparagine at position 149 and N-linked glycosylation at positions 174 and 406. These are UniProt sequence coordinates; antibody or paper numbering may differ. Record the sites when comparing preparations, but do not assign a band shift to a modification without supporting evidence.

Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.

Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.

Blocking · Standard workflow guidance: follow the M02057-3 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.

Quantitation · Because C1S is found in secreted and cell-surface locations, quantify comparable sample fractions and use the same preparation conditions across samples. Define the band being measured consistently; no empirical C1S band position is supplied.

Interpretation · The predicted 76.7 kDa refers to the listed sequence. C1S has a signal peptide at residues 1–15 and N-linked glycosylation sites at 174 and 406, so its apparent mobility may differ. No observed band size is supplied, and these features alone do not establish a visible shift.

C1S has 13 annotated disulfide bonds. Compare samples prepared under consistent reducing conditions when judging band position or intensity. The supplied features do not specify which bands, if any, will change.

C1S is annotated as secreted and cell-surface-associated. Choose the fraction that matches the question, and compare the same fraction across samples. Its cell-surface annotation notes recruitment to pathogens by the C1Q subcomplex.

C1S is a core component of the calcium-dependent C1 complex, which contains two C1S molecules, two C1R molecules, and one C1Q subcomplex. Consider complex association when interpreting higher-mass signals under conditions that preserve complexes; the record does not establish that such a band will appear.

Check whether the band is being compared with the 76.7 kDa sequence prediction, and document sample fraction and reducing conditions. The signal peptide, two glycosylation sites, and 13 disulfide bonds are relevant context, but the supplied features cannot identify an unexpected band on their own.